Archives

  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-07
  • Proteolytic Neuroligin 1 Fragments Sustain Social Memory in

    2026-04-17

    Proteolytic Neuroligin 1 Fragments Sustain Social Memory in Mice

    Study Background and Research Question

    Memory is a multifaceted phenomenon, encompassing the rapid formation of short-term traces and the long-lasting persistence of long-term memories. While the molecular and synaptic underpinnings of memory formation and consolidation have been extensively studied, the specific mechanisms responsible for maintaining recently acquired memories—particularly social memories—over intermediate timescales remain less clear. Social memory, or the ability to recognize and remember conspecifics, is crucial for adaptive behaviors and is disrupted in disorders such as Alzheimer’s disease, autism spectrum disorder, and schizophrenia (Liu et al., 2025). Previous work has implicated the dorsal CA2 (dCA2) and ventral hippocampus (vHPC) in the formation of short-term social memories, yet the molecular events sustaining these memories after initial encoding were unknown.

    Key Innovation from the Reference Study

    Liu et al. present compelling evidence that acute social interactions trigger proteolytic processing of neuroligin 1 (NLG1), a synaptic adhesion molecule, specifically in the vHPC. This processing requires sequential activity of α- and γ-secretases, ultimately producing a C-terminal fragment (NLG1-CTD) within neurons. The study demonstrates that NLG1-CTD, through its PDZ binding domain (PBD), is essential for maintaining social memory, acting via the cofilin signaling pathway to regulate synaptic spine stability. Notably, manipulations that prevent NLG1 cleavage or block cofilin phosphorylation impair the maintenance—but not initial formation—of social memories. Conversely, supplementation with a Tat-conjugated PBD peptide rescues maintenance deficits, highlighting the therapeutic potential of targeting this pathway (Liu et al., 2025).

    Methods and Experimental Design Insights

    The authors employed a combination of behavioral assays, pharmacological manipulations, genetic modifications, and molecular analyses to dissect the role of NLG1 proteolysis. Mice were exposed to novel conspecifics, and the maintenance of social memory was assessed using sequential social recognition paradigms. Protease inhibitors targeting α- and γ-secretases were locally infused into the vHPC to block NLG1 processing. In parallel, CRISPR-mediated deletion of the γ-secretase recognition site on NLG1 was performed. The functional consequences of these manipulations were interrogated via social memory retention tests, synaptic morphology analyses (including dendritic spine quantification), and assays of downstream signaling molecules such as cofilin phosphorylation. Rescue experiments utilized cell-permeant peptides mimicking the NLG1-CTD PDZ domain to restore signaling in deficient animals.

    Protocol Parameters

    • assay | social memory retention paradigm | 30–120 min post-exposure | mice, vHPC targeting | assesses maintenance phase distinct from initial acquisition | paper
    • compound administration | γ-secretase inhibitor (local, vHPC) | 10 μM | acute microinfusion | blocks NLG1-CTD generation, tests protease dependency | paper
    • peptide supplementation | Tat-PBD (cell-permeant peptide) | 1 μg/μl, 1 μl | vHPC infusion | rescues cofilin phosphorylation and memory maintenance | paper
    • molecular analysis | cofilin phosphorylation (western blot) | normalized to total cofilin | vHPC tissue | readout of downstream pathway activation | paper
    • workflow recommendation | JNK pathway agonist (e.g., Anisomycin) | 5–20 μM, in vitro | for parallel interrogation of stress-activated kinase signaling in memory maintenance | workflow_recommendation

    Core Findings and Why They Matter

    The study provides direct evidence that social novelty triggers proteolytic cleavage of NLG1 in the vHPC, generating an intracellular fragment (NLG1-CTD) critical for the maintenance—but not encoding—of social memory. Inhibiting either α- or γ-secretase blocks NLG1-CTD production, reduces cofilin phosphorylation, destabilizes dendritic spines, and selectively impairs the persistence of social memory traces. Notably, NLG1-CTD supplementation via a Tat-PBD peptide can restore both molecular signaling and behavioral performance, even in the face of protease inhibition or genetic deletion. The findings reveal a mechanistic bridge linking synaptic adhesion molecule proteolysis to the cytoskeletal remodeling necessary for memory persistence, offering new entry points for therapeutic research in memory-related disorders (Liu et al., 2025).

    Comparison with Existing Internal Articles

    Recent internal analyses have outlined the utility of JNK pathway agonists (notably Anisomycin) in apoptosis and neurobiological research. For example, "Anisomycin as a Potent JNK Agonist: Unlocking Apoptosis and Memory Maintenance Mechanisms" highlights how JNK pathway activation intersects with mechanisms of synaptic plasticity and memory processes. While Liu et al. do not directly investigate JNK signaling, their findings on NLG1-CTD/cofilin-dependent spine remodeling suggest parallel or converging pathways with those modulated by pharmacological JNK agonists. Similarly, "Translating JNK Pathway Activation into Research Impact" discusses emerging intersections between JNK activation, apoptosis, and memory maintenance, emphasizing how tools like Anisomycin offer experimental leverage in dissecting these processes. The reference study provides a complementary, proteolysis-driven mechanism, broadening the molecular landscape available for mechanistic investigation in memory research.

    Limitations and Transferability

    Despite its strengths—including precise genetic and pharmacological manipulations—the study is limited by its reliance on acute mouse models and localized manipulations within the vHPC. It is yet to be determined how broadly the NLG1-CTD/cofilin axis generalizes to other forms of memory or to human brain circuits. The focus on the maintenance phase leaves open questions regarding the interplay between proteolytic fragments and other signaling cascades, such as JNK pathway activation, in different cell types or brain regions. Furthermore, the use of exogenous Tat-PBD peptides as a rescue strategy, while mechanistically informative, may not fully recapitulate endogenous regulatory dynamics (Liu et al., 2025).

    Why this cross-domain matters, maturity, and limitations

    The intersection of synaptic proteolysis and cytoskeletal signaling (e.g., via cofilin) with canonical stress-activated pathways such as JNK opens avenues for multi-target experimental designs. However, direct evidence linking NLG1-CTD activity to JNK pathway activation in the context of social memory is not established in this study. Researchers should therefore apply caution in extrapolating these findings to JNK-dependent memory regulation without further experimental validation (Liu et al., 2025).

    Research Support Resources

    For researchers aiming to investigate related mechanisms—such as the role of kinase signaling in memory maintenance or apoptosis induction in neural systems—validated tools are essential. Anisomycin (SKU B6674) from APExBIO is a potent and specific JNK agonist, widely used to activate the JNK pathway in studies of apoptosis and cellular stress. While not directly tested in the Liu et al. study, Anisomycin can support workflows that interrogate convergent kinase and cytoskeletal pathways relevant to memory persistence and synaptic remodeling (workflow_recommendation). Researchers are encouraged to integrate such tools, alongside protease inhibitors and targeted peptides, to construct multi-level investigations into the molecular underpinnings of memory maintenance.